Tributary Capital Management LLC Purchases 7,436 Shares of Addus HomeCare Corporation (NASDAQ:ADUS)

Tributary Capital Management LLC grew its holdings in shares of Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 3.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 214,567 shares of the company's stock after buying an additional 7,436 shares during the quarter. Addus HomeCare accounts for about 1.9% of Tributary Capital Management LLC's investment portfolio, making the stock its 18th largest holding. Tributary Capital Management LLC owned about 1.18% of Addus HomeCare worth $21,219,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Natixis boosted its stake in shares of Addus HomeCare by 111.9% during the 4th quarter. Natixis now owns 250 shares of the company's stock valued at $31,000 after buying an additional 132 shares during the last quarter. Meeder Asset Management Inc. purchased a new position in shares of Addus HomeCare during the 4th quarter valued at approximately $77,000. Harvest Fund Management Co. Ltd purchased a new position in shares of Addus HomeCare during the 4th quarter valued at approximately $86,000. Cibc World Markets Corp purchased a new position in shares of Addus HomeCare during the 4th quarter valued at approximately $204,000. Finally, Atria Investments Inc bought a new position in Addus HomeCare during the fourth quarter worth $209,000. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 2,045 shares of Addus HomeCare stock in a transaction that occurred on Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total value of $235,175.00. Following the transaction, the executive vice president directly owned 7,796 shares of the company's stock, valued at $896,540. The trade was a 20.78% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 4.60% of the company's stock.

Analysts Set New Price Targets

ADUS has been the topic of several research analyst reports. JMP Securities restated a "market outperform" rating and set a $150.00 price objective on shares of Addus HomeCare in a research note on Wednesday. Wall Street Zen upgraded Addus HomeCare from a "hold" rating to a "buy" rating in a research note on Sunday, June 29th. Finally, Macquarie restated an "outperform" rating and set a $133.00 price objective on shares of Addus HomeCare in a research note on Tuesday, June 10th. Seven equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus price target of $142.57.

Addus HomeCare Stock Performance

Shares of NASDAQ ADUS traded down $2.66 during midday trading on Friday, reaching $107.03. 136,336 shares of the company traded hands, compared to its average volume of 165,852. Addus HomeCare Corporation has a 52 week low of $88.96 and a 52 week high of $136.72. The stock has a 50-day moving average price of $112.52 and a 200 day moving average price of $110.14. The company has a debt-to-equity ratio of 0.20, a current ratio of 1.74 and a quick ratio of 1.74. The company has a market cap of $1.97 billion, a price-to-earnings ratio of 24.16, a PEG ratio of 1.54 and a beta of 0.81.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings results on Monday, May 5th. The company reported $1.42 earnings per share for the quarter, beating analysts' consensus estimates of $1.33 by $0.09. Addus HomeCare had a return on equity of 9.23% and a net margin of 6.52%. The business had revenue of $337.71 million during the quarter, compared to analyst estimates of $341.66 million. During the same quarter last year, the company posted $1.21 EPS. Addus HomeCare's revenue for the quarter was up 20.3% on a year-over-year basis. Sell-side analysts anticipate that Addus HomeCare Corporation will post 4.59 earnings per share for the current fiscal year.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.